CELL KILLING INDUCED BY DECAY OF I-125 DURING THE CELL-CYCLE - COMPARISON OF I-125 ANTIPYRINE WITH I-125 BOVINE SERUM-ALBUMIN

被引:12
|
作者
MIYAZAKI, N [1 ]
SHINOHARA, K [1 ]
机构
[1] TOKYO METROPOLITAN INST MED SCI, DEPT RADIAT RES, BUNKYO KU, TOKYO 113, JAPAN
关键词
D O I
10.2307/3578355
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The lethal effects induced by the decay of 125I in synchronized L5178Y cells were studied by suicide experiments. We used 125I-antipyrine, which is freely diffusible in cells, and 125I-bovine serum albumin (BSA), which remains outside the cells. Synchronized cells mixed with either 125I- antipyrine or 125I-BSA were frozen and stored at -196°C for various periods to accumulate 125I decays. A clonogenic assay was used to measure the killing of these stored cells. Cells in G1-S and G2-M phases were more sensitive than those in late S phase for both 125I treatments. The ratio of survival in late S to that in G1-S (late S/G1-S) obtained by the decay of 125I-antipyrine, however, was much smaller than that obtained by the decay of 125I-BSA in the dose range examined. These results suggest that Auger electrons emitted from 125I-antipyrine cause a high-LET-type effect. The reason for the high-LET effect must be the intracellular localization of 125I-antipyrine and its closer contact with DNA.
引用
收藏
页码:182 / 186
页数:5
相关论文
共 50 条
  • [31] I-125 LABELING OF HUMAN, RAT AND BOVINE FIBRINOGEN
    RICHTER, M
    CYRANKA, U
    MARKWARDT, F
    [J]. PHARMAZIE, 1990, 45 (03): : 200 - 203
  • [32] RESULTS OF I-125 THERAPY OF THYROTOXICOSIS
    GLANZMANN, C
    HORST, W
    [J]. NUCLEAR MEDICINE-NUKLEARMEDIZIN, 1975, 14 (03): : 207 - 218
  • [33] LABELING METRIZAMIDE (AMIPAQUE) WITH I-125
    SHARMA, HL
    SMITH, AG
    [J]. ACTA RADIOLOGICA-DIAGNOSIS, 1979, 20 (02): : 289 - 291
  • [34] ANALYSIS OF COMMERCIAL I-125 FIBRINOGENS
    WATERHOUSE, PH
    MCLEAN, JR
    [J]. INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY, 1982, 9 (03): : 229 - 229
  • [35] I-125 IMPLANTS FOR CARCINOMA OF THE PROSTATE
    PESCHEL, RE
    FOGEL, TD
    KACINSKI, BM
    KELLY, K
    MATE, TP
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (10): : 1777 - 1781
  • [36] PERSISTENCE OF I-125 IN THYROID - REPLY
    MCDOUGAL.IR
    GILLESPI.FC
    GREIG, WR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (03): : 161 - &
  • [37] THE HALF-LIFE OF I-125
    ALTZITZOGLOU, T
    [J]. APPLIED RADIATION AND ISOTOPES, 1991, 42 (05) : 493 - 494
  • [38] OCULAR MELANOMA, I-125 PLAQUES
    KLINE, RW
    YEAKEL, PD
    [J]. MEDICAL PHYSICS, 1987, 14 (03) : 475 - 475
  • [39] RADIOTHERAPY OF UVEAL MELANOMA WITH I-125
    MEYER, D
    XU, SZ
    FONTANESI, J
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 1197 - 1197
  • [40] I-125 ALDOSTERONE RIA WITH NO CHROMATOGRAPHY/A
    COOMBES, RF
    [J]. CLINICAL CHEMISTRY, 1977, 23 (06) : 1168 - 1168